Position statement of the European Academy of Dermatology and Venereology Task Force on Quality of Life and Patient Oriented Outcomes on quality of life issues in dermatologic patients during the COVID‐19 pandemic
| Autor: | Åke Svensson, Christine Blome, Françoise Poot, Mir-saeed Salek, Servando E Marron, Alina Suru, Andrew Yule Finlay, Jacek C Szepietowski, Francesca Sampogna, Dennis Linder, Lucia Tomas-Aragones, Florence J Dalgard, Carmen Salavastru, Andrea W M Evers, Damiano Abeni, N. Pustišek, L. Manolache, Pavel V Chernyshov, Matthias Augustin, Anthony Bewley |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
Infectious Disease Transmission Patient-to-Professional Venereology Advisory Committees Pneumonia Viral Population MEDLINE Dermatology Skin Diseases SARS‐CoV‐2 Betacoronavirus 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine Quality of life COVID‐19 Health care Pandemic medicine Humans Infection control 030212 general & internal medicine Position Statement education Pandemics Societies Medical Infection Control education.field_of_study treatment SARS-CoV-2 business.industry COVID-19 humanities Europe Infectious Diseases quality of life Periodicals as Topic Coronavirus Infections business Psychosocial |
| Zdroj: | Journal of the European Academy of Dermatology and Venereology Journal of the European Academy of Dermatology and Venereology, 34(8), 1666-1671 |
| ISSN: | 1468-3083 0926-9959 |
| Popis: | The pandemic of COVID‐19 is a global challenge for health care and dermatologists are not standing apart from trying to meet this challenge. The European Academy of Dermatology and Venereology (EADV) has collected recommendations from its Task Forces (TFs) related to COVID‐19. The Journal of the EADV has established a COVID‐19 Special Forum giving free access to related articles. The psychosocial effects of the pandemic, an increase in contact dermatitis and several other skin diseases because of stress, disinfectants and protective equipment use, especially in health care workers, the temporary limited access to dermatologic care, the dilemma whether or not to pause immunosuppressive therapy, and, finally, the occurrence of skin lesions in patients infected by COVID‐19 all contribute to significant quality of life (QoL) impairment. Here we present detailed recommendations of the EADV TF on QoL and Patient Oriented Outcomes on how to improve QoL in dermatologic patients during the COVID‐19 pandemic for several different groups of patients and for the general population. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text